Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$191.51 - $216.16 $50.5 Million - $57 Million
263,500 Added 1029.3%
289,100 $61.3 Million
Q2 2023

Aug 10, 2023

BUY
$187.64 - $206.25 $4.8 Million - $5.28 Million
25,600 New
25,600 $4.93 Million
Q4 2022

Feb 09, 2023

SELL
$117.37 - $139.17 $13.1 Million - $15.5 Million
-111,500 Reduced 88.14%
15,000 $1.93 Million
Q3 2022

Nov 10, 2022

BUY
$135.27 - $180.11 $13.5 Million - $17.9 Million
99,500 Added 368.52%
126,500 $17.3 Million
Q1 2022

May 12, 2022

BUY
$119.61 - $157.85 $3.23 Million - $4.26 Million
27,000 New
27,000 $3.89 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.